ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,357Medicare Part D Prescriptions Filled, Including Refills

Rank: 387 out of 2132

$429K Total Retail Price of All Prescriptions

Rank: 716 out of 2132

253 Patients Receiving at Least One Drug in Part D
98%* Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Michigan
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

20% of this provider’s 253 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 253 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Michigan
FUROSEMIDE 699 694* 82 1 7
LEVOTHYROXINE SODIUM 427 422* 64 2 4
NAMENDA 346 346 26 3 39
KLOR-CON M20 242 242 41 4 76
METOPROLOL TARTRATE 236 231* 40 5 10
LISINOPRIL 212 207* 41 6 3
HYDROCODONE-ACETAMINOPHEN 211 211 36 S3 7 2
DONEPEZIL HCL 209 209 33 8 29
WARFARIN SODIUM 193 188* 36 9 13
CYMBALTA 171 171 11 10 53
CITALOPRAM HBR 161 156* 30 11 25
ALBUTEROL SULFATE 154 154 35 12 105
ATORVASTATIN CALCIUM 135 135 26 13 8
ESCITALOPRAM OXALATE 131 131 17 14 55
TRAMADOL HCL 123 118* 37 15 21
AMLODIPINE BESYLATE 121 116* 33 16 5
SIMVASTATIN 107 107 31 17 1
QUETIAPINE FUMARATE 107 107 12 A 17 64
PREDNISONE 99 99 27 19 40
METFORMIN HCL 98 93* 17 20 9
MIRTAZAPINE 98 98 23 20 56
OMEPRAZOLE 93 88* 36 22 6
ENULOSE 88 <11 <11 23 173
GABAPENTIN 88 83* 20 23 16
TRAZODONE HCL 81 81 26 25 50
HYDROCHLOROTHIAZIDE 78 <11 <11 26 15
BUMETANIDE 77 72* 11 27 83
AZITHROMYCIN 74 74 27 28 44
RANITIDINE HCL 72 72 13 29 32
CLOPIDOGREL 72 72 16 29 17
POTASSIUM CHLORIDE 72 72 22 29 20
TAMSULOSIN HCL 72 72 21 29 23
CEPHALEXIN 69 69 27 33 89
CARVEDILOL 68 63* 16 34 22
AMOXICILLIN 68 68 26 34 111
METOPROLOL SUCCINATE 67 67 16 36 19
FLUTICASONE PROPIONATE 66 61* 20 37 27
OXYBUTYNIN CHLORIDE ER 64 59* 13 38 116
FENTANYL 63 63 14 S2 39 65
ALLOPURINOL 63 63 13 39 31
LORAZEPAM 63 63 22 B 39 37
SERTRALINE HCL 63 63 11 39 24
LANTUS SOLOSTAR 58 53* 14 43 52
RISPERIDONE 57 <11 <11 A 44 86
LEVETIRACETAM 56 51* 11 45 92
CIPROFLOXACIN HCL 56 56 11 45 58
DIOVAN 54 <11 <11 47 88
LOSARTAN POTASSIUM 51 46* 18 48 12
LACTULOSE 51 <11 <11 48 109
CALCITRIOL 50 <11 <11 50 188
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.